Xuequan Yao

1.2k total citations
37 papers, 921 citations indexed

About

Xuequan Yao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuequan Yao has authored 37 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuequan Yao's work include Gastric Cancer Management and Outcomes (7 papers), Cancer-related gene regulation (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Xuequan Yao is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Cancer-related gene regulation (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Xuequan Yao collaborates with scholars based in China. Xuequan Yao's co-authors include Lizong Shen, Jing Zhai, Xiaoyu Wu, Fukun Liu, Ming‐Fang He, Jiajia Shen, Yifen Zhang, Jiaqi Wu, Weisu Li and Che Chen and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Xuequan Yao

35 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuequan Yao China 20 494 313 305 172 149 37 921
Xuelong Jiao China 18 442 0.9× 279 0.9× 295 1.0× 155 0.9× 201 1.3× 43 926
Yongfu Xiong China 19 516 1.0× 254 0.8× 312 1.0× 211 1.2× 102 0.7× 56 1.0k
Yukiko Nishiguchi Japan 20 401 0.8× 208 0.7× 236 0.8× 146 0.8× 92 0.6× 45 837
Zhouyu Ning China 19 500 1.0× 364 1.2× 357 1.2× 134 0.8× 116 0.8× 40 911
Wenlong Zhai China 18 765 1.5× 224 0.7× 450 1.5× 162 0.9× 216 1.4× 59 1.2k
Weihua Ren China 20 661 1.3× 258 0.8× 409 1.3× 115 0.7× 112 0.8× 43 1.1k
Mengyu Sun China 18 489 1.0× 252 0.8× 290 1.0× 183 1.1× 58 0.4× 45 916
Yu Qi China 19 599 1.2× 234 0.7× 305 1.0× 147 0.9× 86 0.6× 55 951
Yuxi Shan China 20 475 1.0× 138 0.4× 268 0.9× 284 1.7× 178 1.2× 62 1.0k

Countries citing papers authored by Xuequan Yao

Since Specialization
Citations

This map shows the geographic impact of Xuequan Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuequan Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuequan Yao more than expected).

Fields of papers citing papers by Xuequan Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuequan Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuequan Yao. The network helps show where Xuequan Yao may publish in the future.

Co-authorship network of co-authors of Xuequan Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xuequan Yao. A scholar is included among the top collaborators of Xuequan Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuequan Yao. Xuequan Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Che, et al.. (2024). Knockdown of TRIP13 inhibits gastric cancer stemness and cisplatin resistance by regulating FBXW7/ENO1 axis. Tropical Journal of Pharmaceutical Research. 23(1). 27–35.
3.
Zou, Kun, Chunyang Luo, Chunjie Xiang, et al.. (2023). Neoadjuvant chemotherapy is linked to an amended anti-tumorigenic microenvironment in gastric cancer. International Immunopharmacology. 127. 111352–111352. 5 indexed citations
4.
5.
Wang, Yaohui, Tiancheng Zhang, Fangyuan Li, et al.. (2023). Neutrophils promote tumor invasion via FAM3C-mediated epithelial-to-mesenchymal transition in gastric cancer. International Journal of Biological Sciences. 19(5). 1352–1368. 22 indexed citations
6.
Zhai, Jing, Jiaqi Wu, Yaohui Wang, et al.. (2021). Prediction of Sensitivity and Efficacy of Clinical Chemotherapy Using Larval Zebrafish Patient-Derived Xenografts of Gastric Cancer. Frontiers in Cell and Developmental Biology. 9. 680491–680491. 11 indexed citations
7.
Liu, Jiayun, Shenlin Liu, Jing Deng, et al.. (2021). ARF3 inhibits proliferation and promotes apoptosis in gastric cancer by regulating AKT and ERK pathway. Acta Biochimica Polonica. 68(2). 223–229. 6 indexed citations
8.
Wu, Zhenfeng, Kun Zou, Guannan Wu, et al.. (2020). A Comparison of Tumor-Associated and Non-Tumor-Associated Gastric Microbiota in Gastric Cancer Patients. Digestive Diseases and Sciences. 66(5). 1673–1682. 36 indexed citations
9.
Wang, Yaohui, Jing Zhai, Tiancheng Zhang, et al.. (2020). Tumor-Associated Neutrophils Can Predict Lymph Node Metastasis in Early Gastric Cancer. Frontiers in Oncology. 10. 570113–570113. 34 indexed citations
10.
Zhai, Jing, Jiajia Shen, Jiaqi Wu, et al.. (2019). Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Letters. 454. 37–43. 206 indexed citations
11.
Jiang, Chao, Qizhi Wang, Huan Wang, et al.. (2019). Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics. Acta Pharmaceutica Sinica B. 10(9). 1694–1708. 35 indexed citations
12.
Wu, Xiao Yu, et al.. (2017). FOXQ1 promotes cancer metastasis by PI3K/AKT signaling regulation in colorectal carcinoma.. PubMed. 9(5). 2207–2218. 32 indexed citations
13.
Wu, Guannan, Jiayun Liu, Zhenfeng Wu, Xiaoyu Wu, & Xuequan Yao. (2017). MicroRNA-184 inhibits cell proliferation and metastasis in human colorectal cancer by directly targeting IGF-1R. Oncology Letters. 14(3). 3215–3222. 31 indexed citations
14.
Wu, Xiaoyu, Guannan Wu, Zhenfeng Wu, Xuequan Yao, & Gang Li. (2016). MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene. Translational Oncology. 9(1). 25–31. 25 indexed citations
15.
17.
Jiang, Chao, Qiong Wang, Weisu Li, et al.. (2015). Cyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancer.. PubMed. 5(6). 2012–21. 13 indexed citations
18.
Wu, Xiaoyu, Zhenfeng Wu, Qinhong Cao, et al.. (2014). Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy. World Journal of Gastroenterology. 20(43). 16268–16268. 19 indexed citations
19.
Wu, Xiaoyu, Che Chen, Xuequan Yao, et al.. (2014). Growth hormone protects colorectal cancer cells from radiation by improving the ability of DNA damage repair. Molecular Medicine Reports. 10(1). 486–490. 14 indexed citations
20.
Wu, Xiaoyu, Fukun Liu, Xuequan Yao, Weisu Li, & Che Chen. (2007). Growth Hormone Receptor Expression is Up-Regulated During Tumorigenesis of Human Colorectal Cancer. Journal of Surgical Research. 143(2). 294–299. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026